Evidence map›Paper›PMID 36204644›Full record

ArticleFrontiers in cellular and infection microbiology2022

Unbiased screen for pathogens in human paraffin-embedded tissue samples by whole genome sequencing and metagenomics.

Ronny Nienhold, Nadine Mensah, Angela Frank, Anne Graber, Jacqueline Koike, Nathalie Schwab, Claudia Hernach, Veronika Zsikla, Niels Willi, Gieri Cathomas and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ronny NienholdInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Nadine MensahInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Angela FrankInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Anne GraberInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Jacqueline KoikeInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Nathalie SchwabInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Claudia HernachInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Veronika ZsiklaInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Niels WilliInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Gieri CathomasInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Baptiste HamelinInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Susanne GrafCentral Laboratory, Cantonal Hospital Baselland, Liestal, Switzerland.
Tobias JuntAutoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research (NIBR), Basel, Switzerland.
Kirsten D MertzInstitute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland.
Novartis Institutes for BioMedical Research

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of bacterial pathogens in formalin fixed, paraffin embedded (FFPE) tissue samples is limited to targeted and resource-intensive methods such as sequential PCR analyses. To enable unbiased screening for pathogens in FFPE tissue samples, we established a whole genome sequencing (WGS) method that combines shotgun sequencing and metagenomics for taxonomic identification of bacterial pathogens after subtraction of human genomic reads. To validate the assay, we analyzed more than 100 samples of known composition as well as FFPE lung autopsy tissues with and without histological signs of infections. Metagenomics analysis confirmed the pathogenic species that were previously identified by species-specific PCR in 62% of samples, showing that metagenomics is less sensitive than species-specific PCR. On the other hand, metagenomics analysis identified pathogens in samples, which had been tested negative for multiple common microorganisms and showed histological signs of infection. This highlights the ability of this assay to screen for unknown pathogens and detect multi-microbial infections which is not possible by histomorphology and species-specific PCR alone.

Indexed as

BacteriaMetagenomicsFormaldehydeHigh-Throughput Nucleotide SequencingHumansParaffin EmbeddingWhole Genome SequencingFormaldehydeinfectionmetagenomicsnext-generation sequencingpathogen identificationpathology

Identifiers

PMID36204644
PMCPMC9530700
OpenAlexW4297906063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.